Ribomic Inc.
Notice Regarding Monthly Exercise Status of the 19th Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)
Published the monthly exercise status for September 2026. Delivered shares: 260,000 shares; stock acquisition rights exercised in September: 2,600 units; ratio to total issued: 2.4%; unexercised rights at the end of the subject month: 8,500,000 shares; exercise resumed from September 24 after the suspension period. Overall exercise-restriction ratio: 0.6%.
Key Figures
- 260,000 shares: Number of shares delivered in the subject month
- 2,600 units: Number of stock acquisition rights exercised in September
- 0.6%: Exercise-restriction ratio (Listing Rules Article 434)
AI要約
Summary of Monthly Exercise Status
Ribomic Inc. disclosed the monthly exercise status for September of the 19th stock acquisition rights issued by third-party allotment. The number of delivered shares was 260,000 shares, and the stock acquisition rights exercised in September totaled 2,600 units, representing 2.4% of the total issued. Unexercised rights were 87,600 units at the end of the previous month and decreased to 85,000 units at month-end. Total issued shares amounted to 56,572,640 shares, and treasury shares were 23,824 shares. Exercise resumed from September 24, and the exercise-restriction ratio was disclosed as 0.6%.
Impact on Shareholders and Outlook
With the resumption of exercise of these stock acquisition rights, a certain degree of potential dilution to shareholders is expected; however, given the limited exercise to date, the short-term dilution impact on shares is expected to be small. Future exercise trends should be monitored through additional disclosures and the next monthly report.
Ribomic Inc.
Company overview · Stock price · Financial data · All IR
